Ovarian follicular cells have innate immune capabilities that modulate their endocrine function.
Oestrogens are pivotal in ovarian follicular growth, development and function, with fundamental roles in steroidogenesis, nurturing the oocyte and ovulation. Infections with bacteria such as Escherichia coli cause infertility in mammals at least in part by perturbing ovarian follicle function, characterised by suppression of oestradiol production. Ovarian follicle granulosa cells produce oestradiol by aromatisation of androstenedione from the theca cells, under the regulation of gonadotrophins such as FSH. Many of the effects of E. coli are mediated by its surface molecule lipopolysaccharide (LPS) binding to the Toll-like receptor-4 (TLR4), CD14, MD-2 receptor complex on immune cells, but immune cells are not present inside ovarian follicles. The present study tested the hypothesis that granulosa cells express the TLR4 complex and LPS directly perturbs their secretion of oestradiol. Granulosa cells from recruited or dominant follicles are exposed to LPS in vivo and when they were cultured in the absence of immune cell contamination in vitro they produced less oestradiol when challenged with LPS, although theca cell androstenedione production was unchanged. The suppression of oestradiol production by LPS was associated with down-regulation of transcripts for aromatase in granulosa cells, and did not affect cell survival. Furthermore, these cells expressed TLR4, CD14 and MD-2 transcripts throughout the key stages of follicle growth and development. It appears that granulosa cells have an immune capability to detect bacterial infection, which perturbs follicle steroidogenesis, and this is a likely mechanism by which ovarian follicle growth and function is perturbed during bacterial infection.
Herath
Shan
S
Department of Veterinary Clinical Sciences, Royal Veterinary College, University of London, Royal College Street, London NW1 0TU, UK.
Williams
Erin J
EJ
Lilly
Sonia T
ST
Gilbert
Robert O
RO
Dobson
Hilary
H
Bryant
Clare E
CE
Sheldon
I Martin
IM
D000735:Androstenedione / Q000032:analysis; D000818:Animals; D000954:Antigens, Surface / Q000032:analysis*; D001424:Bacterial Infections / Q000276:immunology*; D002417:Cattle; D002478:Cells, Cultured; D005260:Female; D012739:Gonadal Steroid Hormones / Q000032:analysis / Q000378:metabolism*; D006107:Granulosa Cells / Q000276:immunology; D018950:Lipopolysaccharide Receptors / Q000032:analysis; D008070:Lipopolysaccharides / Q000494:pharmacology; D051218:Lymphocyte Antigen 96 / Q000032:analysis; D009569:Nitric Oxide / Q000032:analysis; D006080:Ovarian Follicle / Q000276:immunology* / Q000378:metabolism; D011863:Radioimmunoassay; D013799:Theca Cells / Q000276:immunology; D051197:Toll-Like Receptor 4 / Q000032:analysis; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D000954:Antigens, Surface; D012739:Gonadal Steroid Hormones; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D051218:Lymphocyte Antigen 96; D051197:Toll-Like Receptor 4; D014409:Tumor Necrosis Factor-alpha; D009569:Nitric Oxide; D000735:Androstenedione